Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[GH therapy in Prader-Willi syndrome].

Shinobu Ida1

  • 1Division of Pediaric Endocrinology, Osaka Medical Center and Research Institute for Maternal and Child Health.

Clinical Calcium
|March 19, 2005
PubMed
Summary

Growth hormone (GH) treatment improves growth and body composition in Prader-Willi syndrome (PWS) patients. Combining GH with diet therapy is crucial for managing PWS effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrocortisone dosage at 3 years of age is positively correlated with body mass index at 10 years in individuals with 21-hydroxylase deficiency.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology·2026
Same author

A case of congenital hypopituitarism harboring a nonsense variant in the <i>LHX4</i> gene.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology·2025
Same author

Changes in body mass index during chemotherapy are positively associated with height outcome in childhood cancer survivors of acute lymphoblastic leukemia.

Endocrine journal·2025
Same author

An Exploratory Cross-Sectional Study on Thyroid Hormone Reference Intervals in Children With Down syndrome.

Clinical endocrinology·2025
Same author

Two Novel <i>SLC5A5</i> Variants (Q263L and G350D) Causing Congenital Hypothyroidism.

Thyroid : official journal of the American Thyroid Association·2025
Same author

Genetic backgrounds and genotype-phenotype relationships in anthropometric parameters of 116 Japanese individuals with Noonan syndrome.

Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology·2024

Area of Science:

  • Genetics
  • Endocrinology
  • Pediatrics

Context:

  • Prader-Willi syndrome (PWS) is a complex genetic disorder.
  • Key PWS symptoms include short stature, obesity, hypotonia, and hypogonadism, indicating hypothalamic dysfunction.
  • PWS patients often exhibit reduced growth hormone (GH) secretion and low insulin-like growth factor (IGF-I).

Purpose:

  • To evaluate the efficacy and impact of growth hormone (GH) treatment in patients with Prader-Willi syndrome (PWS).
  • To explore the effects of GH therapy on growth, body composition, and associated PWS symptoms.
  • To determine the optimal therapeutic strategies for managing PWS, including combination therapies.

Summary:

  • GH treatment in PWS patients effectively promotes growth and improves body composition by reducing fat mass and increasing muscle mass.
  • Therapeutic benefits include enhanced respiratory function and bone mineral density.
  • Potential adverse effects such as diabetes mellitus and respiratory dysfunction necessitate careful monitoring.
  • Combined therapy, particularly with diet, is essential for maximizing GH treatment benefits in PWS.

Impact:

  • GH therapy offers significant improvements in physical development and metabolic health for individuals with PWS.
  • Understanding the multifaceted effects of GH treatment guides clinical practice and patient management strategies.
  • This research highlights the importance of integrated treatment approaches for complex genetic disorders like PWS.

Related Experiment Videos